Jane Street’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32M | Buy |
192,600
+14,000
| +8% | +$2.3M | ﹤0.01% | 1383 |
|
|
2025
Q4 | $28.5M | Sell |
178,600
-17,195
| -9% | -$2.36M | ﹤0.01% | 1304 |
|
|
2025
Q3 | $18.3M | Buy |
195,795
+51,100
| +35% | +$3.61M | ﹤0.01% | 1743 |
|
|
2025
Q2 | $8.23M | Buy |
144,695
+43,295
| +43% | +$2.3M | ﹤0.01% | 2380 |
|
|
2025
Q1 | $6.18M | Buy |
101,400
+21,640
| +27% | +$1.84M | ﹤0.01% | 2609 |
|
|
2024
Q4 | $7.18M | Buy |
79,760
+24,605
| +45% | +$2.89M | ﹤0.01% | 2222 |
|
|
2024
Q3 | $7.1M | Buy |
+55,155
| New | +$7.2M | ﹤0.01% | 2331 |
|
|
2022
Q2 | – | Sell |
-18,940
| Closed | -$5.94M | – | 10346 |
|
|
2022
Q1 | $5.94M | Sell |
18,940
-7,200
| -28% | -$2.71M | ﹤0.01% | 2748 |
|
|
2021
Q4 | $18.8M | Sell |
26,140
-6,285
| -19% | -$6.02M | 0.01% | 1264 |
|
|
2021
Q3 | $35.9M | Buy |
32,425
+14,295
| +79% | +$17.6M | 0.01% | 753 |
|
|
2021
Q2 | $26.7M | Sell |
18,130
-1,165
| -6% | -$1.62M | 0.01% | 874 |
|
|
2021
Q1 | $30.5M | Sell |
19,295
-14,155
| -42% | -$33.2M | 0.02% | 694 |
|
|
2020
Q4 | $67.2M | Buy |
33,450
+5,960
| +22% | +$9.5M | 0.03% | 358 |
|
|
2020
Q3 | $29.4M | Buy |
27,490
+15,710
| +133% | +$18M | 0.02% | 586 |
|
|
2020
Q2 | $14M | Buy |
11,780
+2,690
| +30% | +$2.33M | 0.01% | 960 |
|
|
2020
Q1 | $4.1M | Sell |
9,090
-6,845
| -43% | -$6.23M | ﹤0.01% | 1337 |
|
|
2019
Q4 | $18.3M | Buy |
15,935
+1,950
| +14% | +$1.75M | 0.03% | 407 |
|
|
2019
Q3 | $8.64M | Sell |
13,985
-8,245
| -37% | -$6.85M | 0.01% | 669 |
|
|
2019
Q2 | $22.3M | Buy |
22,230
+1,855
| +9% | +$1.8M | 0.04% | 345 |
|
|
2019
Q1 | $24.4M | Sell |
20,375
-5,670
| -22% | -$5.9M | 0.04% | 354 |
|
|
2018
Q4 | $17.1M | Buy |
26,045
+3,790
| +17% | +$3.97M | 0.04% | 369 |
|
|
2018
Q3 | $41.4M | Buy |
22,255
+13,610
| +157% | +$26.7M | 0.08% | 163 |
|
|
2018
Q2 | $16.4M | Sell |
8,645
-10,305
| -54% | -$18.2M | 0.04% | 381 |
|
|
2018
Q1 | $30.1M | Buy |
18,950
+8,495
| +81% | +$15.8M | 0.08% | 194 |
|
|
2017
Q4 | $16.3M | Buy |
10,455
+3,840
| +58% | +$5.88M | 0.05% | 345 |
|
|
2017
Q3 | $11.3M | Sell |
6,615
-6,305
| -49% | -$8.75M | 0.04% | 472 |
|
|
2017
Q2 | $16.3M | Sell |
12,920
-955
| -7% | -$963K | 0.06% | 291 |
|
|
2017
Q1 | $13.2M | Buy |
13,875
+1,550
| +13% | +$1.38M | 0.06% | 298 |
|
|
2016
Q4 | $7.72M | Buy |
12,325
+4,615
| +60% | +$3.47M | 0.03% | 462 |
|
|
2016
Q3 | $7.52M | Sell |
7,710
-1,106
| -13% | -$912K | 0.04% | 405 |
|
|
2016
Q2 | $4.98M | Buy |
8,816
+1,723
| +24% | +$1.08M | 0.02% | 639 |
|
|
2016
Q1 | $3.89M | Buy |
7,093
+6,048
| +579% | +$3.83M | 0.02% | 697 |
|
|
2015
Q4 | $1.76M | Buy |
+1,045
| New | +$1.69M | 0.01% | 1200 |
|
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
Jane Street's LABU Position: Q2 2025 in Review
Jane Street sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 73,118 shares — an estimated $3.88M sold.
Jane Street first reported a position in LABU in Q3 2015 and held it in 32 quarters. The position peaked at $9.92M in Q4 2023. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.
- Jane Street reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
- Jane Street sold 73,118 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $3.88M.
- Jane Street first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and held it in 32 quarters.
- Jane Street's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.92M in Q4 2023.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.